Literature DB >> 16953950

Short report: antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including beta-lactamase-negative ampicillin-resistant strains.

L Qin1, H Watanabe, N Asoh, K Watanabe, K Oishi, T Mizota, T Nagatake.   

Abstract

The minimum inhibitory concentration (MIC) of five antibiotics and the presence of resistance genes was determined in 163 Haemophilus influenzae isolates collected over 13 years (1987-2000) in four two-yearly sampling periods from patients with respiratory tract infections. The prevalence of beta-lactamase-negative ampicillin-susceptible strains was approximately 80% over the sampling period although fewer strains (65.9%) were recovered in the period 1995-1997. TEM-1 type beta-lactamase-producing strains were less frequent starting at 15.6% and declining to 2.2% in the final sampling period. Low-beta-lactamase-negative ampicillin-resistant (BLNAR) strains were uncommon in 1987-1989 (2.2%), peaked to 19.5% in 1995-1997, but fell back to 11.1% by 2000. Fully BLNAR strains were not detected until the last sampling period (6.7%). The MICs of ampicillin, levofloxacin, cefditoren and ceftriaxone remained stable but there was an eight-fold increase in the MIC of cefdinir over the sampling period. Pulsed-field gel electrophoresis of DNA digests showed that three representative BLNAR strains were genetically distinct and 11 DNA profiles were identified among 17 low-BLNAR strains. These data suggest that the number of genetically altered BLNAR and low-BLNAR strains are increasing in Japan.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16953950      PMCID: PMC2870599          DOI: 10.1017/S0950268806007023

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  16 in total

1.  Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain.

Authors:  James A Karlowsky; Ian A Critchley; Renée S Blosser-Middleton; Elena A Karginova; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.

Authors:  K Ubukata; Y Shibasaki; K Yamamoto; N Chiba; K Hasegawa; Y Takeuchi; K Sunakawa; M Inoue; M Konno
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending a day care center.

Authors:  H Yano; M Suetake; A Kuga; K Irinoda; R Okamoto; T Kobayashi; M Inoue
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan.

Authors:  Kenji Suzuki; Tadao Nishimura; Shunkichi Baba
Journal:  J Infect Chemother       Date:  2003-03       Impact factor: 2.211

5.  Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens--findings of the Alexander Project 1992-1996.

Authors:  D Felmingham; J Washington
Journal:  J Chemother       Date:  1999-02       Impact factor: 1.714

6.  Clonal spread of an invasive strain of Haemophilus influenzae type b among nursery contacts accompanied by a high carriage rate of non-disease-associated strains.

Authors:  Mitsumasa Saito; Kenji Okada; Kouichi Takemori; Shin-Ichi Yoshida
Journal:  J Med Microbiol       Date:  2000-09       Impact factor: 2.472

Review 7.  Antimicrobial resistance in Haemophilus influenzae: how can we prevent the inevitable? Commentary on antimicrobial resistance in H. influenzae based on data from the TARGETed surveillance program.

Authors:  Robert P Rennie; Khalid H Ibrahim
Journal:  Clin Infect Dis       Date:  2005-08-15       Impact factor: 9.079

8.  The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.

Authors:  Daryl Hoban; David Felmingham
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

9.  Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999.

Authors:  F Marco; J García-de-Lomas; C García-Rey; E Bouza; L Aguilar; C Fernández-Mazarrasa
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Increasing prevalence of ampicillin- resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan.

Authors:  H Seki; Y Kasahara; K Ohta; Y Saikawa; R Sumita; A Yachie; S Fujita; S Koizumi
Journal:  Chemotherapy       Date:  1999 Jan-Feb       Impact factor: 2.544

View more
  4 in total

Review 1.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

2.  Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel.

Authors:  Kimberley Clawson Stone; Ron Dagan; Adriano Arguedas; Eugene Leibovitz; Elaine Wang; Roger M Echols; Nebojsa Janjic; Ian A Critchley
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

3.  Polymorphism in ftsI gene and {beta}-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of beta-lactamase-positive isolates with decreased susceptibility to amoxicillin/clavulanic acid.

Authors:  Ana Raquel Barbosa; Maria Giufrè; Marina Cerquetti; Maria Paula Bajanca-Lavado
Journal:  J Antimicrob Chemother       Date:  2011-01-25       Impact factor: 5.790

4.  Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan.

Authors:  Muneki Hotomi; Keiji Fujihara; Dewan S Billal; Kenji Suzuki; Tadao Nishimura; Shunkichi Baba; Noboru Yamanaka
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.